iRadimed IRMD Additional Paid-In Capital
Additional Paid-In Capital at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.
The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about iRadimed's additional paid-in capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is iRadimed's additional paid-in capital?
- iRadimed (IRMD) reported additional paid-in capital of $31.02M in Q1 2026.
- How has iRadimed's additional paid-in capital changed year-over-year?
- iRadimed's additional paid-in capital increased by 0.9% year-over-year, from $30.74M to $31.02M.
- What is the long-term trend for iRadimed's additional paid-in capital?
- Over 5 years (2020 to 2025), iRadimed's additional paid-in capital has grown at a 5.1% compound annual growth rate (CAGR), from $23.68M to $30.39M.
- What does additional paid-in capital mean?
- Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.